Shares of Tivity Health Inc (NASDAQ:TVTY) have been given a consensus rating of “Buy” by the ten ratings firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and six have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $45.43.
A number of research analysts have commented on TVTY shares. Oppenheimer upped their price target on Tivity Health from $47.00 to $50.00 and gave the company an “outperform” rating in a research report on Wednesday, November 1st. Zacks Investment Research raised Tivity Health from a “hold” rating to a “buy” rating and set a $52.00 price target for the company in a research report on Tuesday, October 31st. ValuEngine lowered Tivity Health from a “buy” rating to a “hold” rating in a research report on Monday, October 2nd. Jefferies Group reaffirmed a “buy” rating and set a $46.00 price target on shares of Tivity Health in a research report on Monday, September 25th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and set a $45.00 price target on shares of Tivity Health in a research report on Monday, November 6th.
In other Tivity Health news, Director Conan Laughlin sold 140,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 21st. The stock was sold at an average price of $34.90, for a total transaction of $4,886,000.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Mary Flipse sold 5,000 shares of the company’s stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $48.11, for a total value of $240,550.00. Following the transaction, the insider now owns 45,167 shares in the company, valued at approximately $2,172,984.37. The disclosure for this sale can be found here. Insiders have sold a total of 875,892 shares of company stock valued at $31,815,642 in the last ninety days. 8.42% of the stock is currently owned by corporate insiders.
Several hedge funds have recently bought and sold shares of the business. Flinton Capital Management LLC grew its holdings in shares of Tivity Health by 63.5% during the 2nd quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock worth $139,000 after acquiring an additional 1,360 shares during the period. Riverhead Capital Management LLC grew its holdings in shares of Tivity Health by 69.7% during the 2nd quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock worth $142,000 after acquiring an additional 1,464 shares during the period. New York State Teachers Retirement System grew its holdings in shares of Tivity Health by 1.5% during the 3rd quarter. New York State Teachers Retirement System now owns 111,510 shares of the company’s stock worth $4,550,000 after acquiring an additional 1,700 shares during the period. Sawgrass Asset Management LLC grew its holdings in shares of Tivity Health by 31.6% during the 3rd quarter. Sawgrass Asset Management LLC now owns 7,755 shares of the company’s stock worth $316,000 after acquiring an additional 1,860 shares during the period. Finally, SG Americas Securities LLC purchased a new position in shares of Tivity Health during the 3rd quarter worth approximately $210,000.
Tivity Health (TVTY) traded down $0.25 during midday trading on Monday, hitting $36.35. The stock had a trading volume of 368,616 shares, compared to its average volume of 481,325. Tivity Health has a 12 month low of $20.60 and a 12 month high of $48.50. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.60. The company has a market cap of $1,430.00, a price-to-earnings ratio of 23.30, a PEG ratio of 1.95 and a beta of 0.18.
Tivity Health (NASDAQ:TVTY) last released its earnings results on Thursday, October 26th. The company reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.10. Tivity Health had a return on equity of 30.23% and a net margin of 11.45%. The company had revenue of $137.70 million during the quarter, compared to analyst estimates of $137.95 million. The company’s revenue for the quarter was up 10.2% on a year-over-year basis. sell-side analysts anticipate that Tivity Health will post 1.6 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: This piece of content was posted by Equities Focus and is the property of of Equities Focus. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.equitiesfocus.com/2018/01/06/brokerages-set-tivity-health-inc-tvty-target-price-at-45-43.html.
About Tivity Health
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.